According to our latest study on “Intradermal Injection Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Method, Application, and End User,” the market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to grow at a CAGR of 11.3% from 2021 to 2028. The report highlights the key factors driving the intradermal injection market growth and prominent players with their developments in the market.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00019998/
Some Leading Companies Analysis as Below-
- West Pharmaceuticals Services
- Terumo Corporation
- Ensung Global
- Cardinal Health
- Hindustan Syringes and Medical Devices
Over the past two decades, there has been an unprecedented surge in the demand for intradermal injections due to rising incidence of various diseases and increasing acceptance of intradermal vaccination and aesthetic procedures. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By using intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Moreover, there is an increasing demand for less invasive intradermal devices such as intradermal jet injectors, microinjections, and ballistic intradermal injections. As per the WHO’s data, tuberculosis is the 13th leading cause of death and about 10 million cases of TB have been recorded every year.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00019998/
A sudden rise in the diagnostic rate of TB has been observed during the last decade, which is one of the leading reasons for the increasing market size of tuberculin syringes. As the global population is increasing continuously, the number of tuberculosis cases will also rise in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products. Moreover, the number of aesthetic procedures is increasing rapidly in North American and European countries. As per the data of the Aesthetic Plastic Surgery National Databank, more than 7 million aesthetic procedures were performed in US during 2020 among which the leading segment was toxins and fillers with about 3.9 Million procedures.
Worldwide Industry Segments Analysis-
Based on application, the intradermal injection market is segmented tuberculin skin testing, allergy test, local aesthetics, and others. In 2021, the tuberculin skin testing segment would hold the largest share of the market, while the local aesthetic segment is expected to register the highest CAGR in the market during 2021–2028.
The intradermal Injection market is segmented on the basis of method, application, and end user. Based on method, the market is segmented into normal-sized needles, short needles, and without needles. Based on application, the market is segmented into tuberculin skin testing, allergy testing, local aesthetics, and others. Based on the end user, the market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. On the basis of geography, the intradermal injection market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
Purchase this Report at https://www.theinsightpartners.com/buy/TIPRE00019998/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi